PMC:7361216 / 3102-3252 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":37,"end":43},"obj":"Body_part"},{"id":"T35","span":{"begin":55,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":37,"end":43},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":16,"end":26},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T38","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":74,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T27","span":{"begin":55,"end":67},"obj":"Chemical"}],"attributes":[{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T24","span":{"begin":55,"end":67},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T19","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T11","span":{"begin":37,"end":43},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"90","span":{"begin":2,"end":26},"obj":"Disease"},{"id":"82","span":{"begin":37,"end":67},"obj":"Gene"},{"id":"85","span":{"begin":69,"end":72},"obj":"Gene"}],"attributes":[{"id":"A90","pred":"pubann:denotes","subj":"90","obj":"MESH:D003711"},{"id":"A82","pred":"pubann:denotes","subj":"82","obj":"Gene:4099"},{"id":"A85","pred":"pubann:denotes","subj":"85","obj":"Gene:4099"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T34","span":{"begin":37,"end":67},"obj":"Protein"},{"id":"T45","span":{"begin":69,"end":72},"obj":"Protein"}],"attributes":[{"id":"A34","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/Q567S4"},{"id":"A35","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/Q15489"},{"id":"A36","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P20917"},{"id":"A37","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P20916"},{"id":"A38","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P16880"},{"id":"A39","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P07723"},{"id":"A40","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P07722"},{"id":"A41","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P02685"},{"id":"A42","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/F5GYC0"},{"id":"A43","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/B7Z2E5"},{"id":"A44","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/A0A087WPR1"},{"id":"A45","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q567S4"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T34","span":{"begin":37,"end":43},"obj":"Body_part"},{"id":"T35","span":{"begin":55,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T12","span":{"begin":16,"end":26},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T2","span":{"begin":2,"end":15},"obj":"Phenotype"},{"id":"T3","span":{"begin":16,"end":26},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":2,"end":15},"obj":"Phenotype"},{"id":"T3","span":{"begin":16,"end":26},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"82","span":{"begin":37,"end":67},"obj":"Gene"},{"id":"85","span":{"begin":69,"end":72},"obj":"Gene"},{"id":"90","span":{"begin":2,"end":26},"obj":"Disease"}],"attributes":[{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"Gene:4099"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:4099"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:D003711"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Monstad, 2001)."}